by Robert Hayes Posted on April 5, 2024April 5, 2024 BUSINESS BRIEF: Wilmington’s Charles River & Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on January 29, 2024January 29, 2024 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Adds Reshema Kemps-Polanco To Board Of Directors Read More
by Robert Hayes Posted on December 3, 2023December 3, 2023 BUSINESS BRIEF: Wilmington’s Charles River & Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on July 26, 2023July 26, 2023 OBITUARY: Kathleen A. Murray, D.V.M, 68 Read More
by Robert Hayes Posted on April 29, 2023April 29, 2023 Wilmington’s Charles River Labs Named A Top Ten Massachusetts Company For Gender Equity Among Executive Leadership Read More
by Robert Hayes Posted on February 17, 2023February 17, 2023 Wilmington’s Charles River Laboratories & Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration Read More
by Robert Hayes Posted on February 2, 2023February 3, 2023 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Acquires SAMDI Tech For $50 Million Read More
by Robert Hayes Posted on June 28, 2022June 28, 2022 BUSINESS BRIEF: Wilmington’s Charles River Laboratories Announces Opening of U.K. Manufacturing Facility Read More
by Robert Hayes Posted on April 10, 2022April 10, 2022 Wilmington’s Charles River Laboratories Acquires Explora BioLabs Read More
by Robert Hayes Posted on March 28, 2022March 28, 2022 Wilmington’s Charles River Laboratories To Appoint Flavia H. Pease As Chief Financial Officer Read More
Wilmington Apple 
You must be logged in to post a comment.